NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
* Return to Women's Health Alert Section

Reports from Pontificia University Catolica of Chile describe recent advances in polycystic ovarian syndrome therapy



March 9th, 2009

   2009 MAR 9 -- Investigators publish new data in the report 'Scanning electron and light microscopy study of the cervical mucus in women with polycystic ovary syndrome.' "Two types of cervical mucus are recognized, oestrogenic and gestagenic. These are constituted by different subtypes, and their characteristics change depending on variations in the hormonal levels and on the existence of several pathologies," investigators in Chile report.

   "Our aim was to identify the ultrastructure and crystallization characteristics of the cervical mucus in women suffering from polycystic ovary syndrome, and to compare these characteristics with those of normal control women. Cervical mucus samples were taken from 10 women, 4 control group women (with normal ovulatory menstrual cycles) and 6 suffering from polycystic ovary syndrome (2 with ovulatory and 4 with anovulatory cycles). This mucus was characterized according to its ultrastructure and crystallization. The type of mucus obtained was related to the levels of oestradiol and progesterone present when the samples were taken. As regards mucus ultrastructure, differences were found between the control women and those with polycystic ovary syndrome and anovulatory menstrual cycles. Such variations were evident in the type of mesh and the average diameter of the mucus pores. Mucus crystallization in control women showed the usual oestrogenic disposition: fern-like (L, P2), rectilinear (S) or a hexagonal structure (P6). On the other hand, in women with polycystic ovary syndrome, indefinite mucus crystallizations were found, as well as crystallization patches resembling oestrogenic and gestagenic-like mucus. This study shows that the ultrastructure and crystallization characteristics of the cervical mucus in polycystic ovary syndrome women are different from those of control women," wrote P. Vigil and colleagues, Pontificia University Catolica of Chile.

   The researchers concluded: "The latter would be dependent on their levels of oestradiol and progesterone."

   Vigil and colleagues published their study in the Journal of Electron Microscopy (Scanning electron and light microscopy study of the cervical mucus in women with polycystic ovary syndrome. Journal of Electron Microscopy, 2009;58(1):21-7).

   For additional information, contact P. Vigil, Pontificia Universidad Catolica de Chile, Facultad de Ciencias Biologicas, Departamento de Ciencias Fisiologicas, Facultad de Ciencias Biologicas, Av Alameda B O'Higgins 340, Chile.

   The publisher of the Journal of Electron Microscopy can be contacted at: Oxford University Press, Great Clarendon St., Oxford OX2 6DP, England.

   Keywords: Chile, Polycystic Ovarian Syndrome Therapy, Clinical Trial Research, Drugs, Electron Microscopy, Endocrinology, Estrogen, Gynecology, Hormones, Menstruation, Pharmaceuticals, Polycystic Ovarian Syndrome, Polycystic Ovary Syndrome, Progesterone, Therapy, Treatment, Women's Health.

   This article was prepared by Biotech Business Week editors from staff and other reports. Copyright 2009, Biotech Business Week via NewsRx.com.

Return to Women's Health Alert Section

NewsRx Passes
Advertisement
------------------------
Security by Verisign PR Login